InVivo Therapeutics
Cambridge
About InVivo Therapeutics
InVivo Therapeutics Corporation is a medical device company focused on utilizing polymers as a platform technology to develop treatments to restore function in individuals paralyzed as a result of traumatic spinal cord injuries. The company was founded in 2005 on the basis of research initiated in Cambridge, Massachusetts, United States.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Public
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $125.2M
- Funding stage: IPO
- Last round: Post-IPO Equity (Oct 2022)
- Ticker: nasdaq:NVIV
- Website: invivotherapeutics.com
- Phone: +116178635535
Industries & Categories
Biotechnology, Health Care, Medical Device, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/invivo-therapeutics-196372 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.